New Delhi : Drug firm Dr Reddy’s Laboratories said it has launched generic Zoledronic Acid injection used for treating osteoporosis and Paget’s disease of bone in the US market following approval from the US health regulator. The company has launched Zoledronic Acid injection (5 mg/ 100 mL) yesterday, following approval of its abbreviated new drug application (ANDA) by the US Food & Drug Administration (USFDA), Dr Reddy’s Laboratories said in a statement.
